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Abiotrophia defectiva, a nutritionally variant streptococci can cause bacteremia, brain abscess, septic arthritis and in rare cases, 
infective endocarditis, which accounts for 5-6% of all cases. A. defectiva is characteristically difficult to diagnose and the mor-
tality, morbidity and complication rates are high. Here, we discuss a case of infective endocarditis caused by A. defectiva. A 
62-year-old female had previously undergone prosthetic valve replacement 6 years prior to admission. She developed infective 
endocarditis after tooth extraction. Her endocarditis was successfully treated with antimicrobial therapy and mitral valve re-
placement surgery. This is the first case of infective endocarditis caused by A. defectiva reported in Korea. This case shows that A. 
defectiva could be considered as a causative organism of infective endocarditis in Korea.
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Introduction
Abiotrophia defectiva is part of the normal human microbi-
ota, colonizing the oral, genitourinary, and intestinal tracts [1]. 
It is a rare, yet important, cause of infective endocarditis, and 
is estimated to cause approximately 5-6% of all cases of infec-
tive endocarditis, including being a major cause of blood cul-
ture-negative infective endocarditis [2]. It affects diseased 
valves in 90% of cases and it is implicated in embolic compli-
cations and valvular destruction, despite being sensitive to 
antibiotics [3]. Previous studies have shown mortality and re-
lapse rates as high as 17% despite antibiotic treatment, and 
this makes accurate and quick identification important [4-6]. 
Herein we report the first case of infective endocarditis caused 
by A. defectiva in Korea.
Case Report
A 62-year-old female was admitted to the emergency de-
partment (ED) after two consecutive episodes of syncope. The 
patient was diagnosed with severe rheumatic mitral stenosis, 
and underwent a mitral valve replacement (MVR). Two 
months previously, the patient had undergone a simple ex-
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traction of her #16 tooth due to secondary dental caries and 
had taken prophylactic antibiotics (amoxicillin 2,000 mg). 
Upon admission to the ED the patient was alert and had a 
body temperature of 38.6°C, a pulse rate of 66 beats/min, and 
blood pressure of 149/51 mmHg. Upon physical examination, 
no cardiac murmur was auscultated and no other evidence, 
such as clubbed fingers, Janeway lesions or petechiae were 
found. Laboratory studies showed a white blood cell count of 
14,260/mm3(neutrophil 79.6%), erythrocyte sediment rate of 
92 mm/h and C-reactive protein of 111.1 mg/L. Chest X-ray 
revealed mild cardiomegaly and electrocardiography showed 
a newly developed complete atrioventricular block. Chest CT 
and abdominal-pelvic CT was performed to evaluate fever fo-
cus, which showed no significant finding.
A transthoracic echocardiogram (TTE) showed that the me-
chanical prosthetic mitral valve functioned well, and there 
was no visible vegetation, however, infective endocarditis 
could not be completely ruled out because of the patient’s 
previous MVR. Thus, empirical antibiotics (vancomycin 1 g 
intravenous q12hr, gentamicin 60 mg intravenous q8hr and ri-
fampin 600 mg per oral q24hr) were administered, and a 
transesophageal echocardiogram (TEE) performed the day 
after admission showed mitral valve vegetation and mild 
transvalvular mitral regurgitation (Fig. 1), leading to a conclu-
sive diagnosis of infective endocarditis according to Duke cri-
teria (one major and three minor criteria).
Three sets of blood cultures taken on admission showed tiny, 
non-hemolytic colonies on a blood agar plate (ASAN Pharma-
ceutical, Hwaseong, Korea), and pleomorphic Gram-positive 
cocci from smear preparation of the blood agar plate (Fig. 2). 
On the third day after admission, A. defectiva was identified by 
MALDI-TOF-MS (Matrix-assisted laser desorption/ionization 
time-of-flight mass spectrometry, Bruker Daltonics Inc., MA, 
USA), not identified in VITEK 2 (bioMérieux, Marcy l'Etoile, 
France) systems . However, because the amount of bacteria 
was insufficient, cultures were sub-cultured on a medium con-
taining vitamin B6 to assess antibiotic susceptibility. 
Susceptibility to cefotaxime, penicillin G and vancomycin 
was tested by the E-test method; the isolate tested cefotax-
ime-sensitive (MIC 0.75 μg/mL), penicillin G-intermediate 
(MIC 1.0 μg/mL) and vancomycin-sensitive (MIC 0.38 μg/
mL). An adjusted antibiotic regimen of vancomycin 1 g q12hr 
and gentamicin 60 mg q8hr was initiated, after which the pa-
tient’s fever subsided. Vancomycin Therapeutic drug monitor-
ing was performed, and vancomycin dosage was adjusted to 
400 mg q12hr.
On day 12 of admission, the patient became feverish once 
more and in the subsequent TEE the mitral valve vegetation 
on the medial side seemed to have resolved, but there was an 
increase in the size of the vegetation on the lateral annulus 
(0.5 × 0.3 cm − 0.8 × 0.3 cm) which indicated a perivalvular 
infection (Fig. 1). Based on these findings, a second MVR was 
performed on day 19 of admission. 
Operation finding showed small vegetation in prosthetic MV 
and annulus, which was removed, and MVR was conducted 
using 23 mm ATS medical open pivot heart valve (ATS Medi-
cal, Inc., Minneapolis, MN, USA). Pathology finding showed 
myxoid degeneration, acute and chronic inflammation, fibro-
sis and calcification, and tissue culture showed no growth of 
organism (It was on the 19th day on antibiotics, and blood cul-
Figure 1. Transesophageal echocardiography performed the day after 
admission. (A) Long-axis view (135°) of a transesophageal echocardiogra-
phy showing two examples of vegetation attached to the prosthetic mitral 
valve. The larger one measures 0.7 × 0.5 cm (large arrowhead) and the 
smaller one measures 0.5 × 0.3 cm (small arrowhead). (B) Two-chamber 
view (59°) of a transesophageal echocardiography (zoomed view) showing 
vegetation attached to the prosthetic mitral valve (arrowhead). A color 
Doppler shows the jet flow with mild transvalvular mitral regurgitation in 
systole (arrow). 
LA, left atrium; LV, left ventricle; RV, right ventricle.
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ture was negatively converted at this time).
On day 23 of admission, a follow-up TTE showed a 
well-functioning prosthetic mitral valve. The patient was treat-
ed with antibiotics for 5 weeks and was discharged on day 36. 
The patient was followed-up at an out-patient clinic for 3 
months after discharge with no significant complications. 
Discussion
Organisms of the genus Abiotrophia were first classified as 
nutritionally variant streptococci (NVS) in 1961 [6]. Bouvet et 
al. identified two species of NVS; Streptococcus defectivus and 
Streptococcus adjacens [7]. In 1995, Kawamura et al. identified 
Abiotrophia as a separate genus, based on 16S rRNA analyses 
[8]. NVS are part of the normal flora of the mouth and urogen-
ital and intestinal tracts [1]. Recently, an increasing number of 
cases have been described of A. defectiva isolates recovered 
from invasive and non-invasive infections following dental 
procedures [9]. 
Abiotrophia spp., has fastidious culturing and the unspecific 
colony morphology that they presents on primary detection, 
such strains have caused major diagnostic difficulties. Thus, it 
has been supposed that many culture-negative endocarditis 
could have been caused by these species, which could have 
lead to an underestimation as pathogens of infective endocar-
ditis [10]. In this case report, we identified A.defectiva by 
MALDI-TOF-MS. MALDI-TOF-MS is a new technology for 
routine identification of bacteria in clinical microbiology lab-
oratories. Much of the work using MALDI-TOF-MS for micro-
bial identification has focused on demonstrating that repro-
ducible mass spectra can be obtained using intact cells and 
developing algorithms for interpretation and comparison of 
these spectra. By testing colonies, it takes only a few minutes 
to have a correct identification which makes not only possible 
to identify the microorganisms at the species levels but some-
times at the sub-species and strains levels, allowing the detec-
tion of epidemic lineages [11]. 
A. defectiva can cause serious infections such as bactere-
mia, osteomyelitis, brain abscess, pancreatic abscess, septic 
arthritis, crystalline keratopathy and in rare cases, infective 
endocarditis [3, 12]. Endocarditis caused by NVS is implicated 
in 5−6% of all streptococcal endocarditis cases, and <1% of all 
endocarditis cases are caused by A. defective [3]. However, A. 
defectiva has a higher affinity for the endocardium because of 
its ability secrete exopolysaccharide, enabling it to adhere to 
fibronectin in the extracellular matrix [2]. Of all the NVS-in-
duced endocarditis patients, 90% suffered from heart disease, 
and in most cases, bacteremia associated with the pre-existing 
valvular heart disease led to the development of endocarditis 
with subacute prognoses [13]. 
Infective endocarditis caused by A. defectiva and other NVS 
had higher mortality, morbidity and complication rates than 
those caused by other viridans streptococci [14]. Most deaths 
were due to refractory congestive cardiac failure or major sys-
temic emboli [15]. A mortality rate of up to 17% has been re-
Figure 2. Colony and microscopic characteristics of Abiotrophia defective. Tiny, non-hemolytic colonies on a blood agar plate (ASAN Pharmaceutical, 
Hwaseong, Korea) after 48 hour of incubation at 35°C with 5% CO2 (left), and pleomorphic Gram-positive cocci from smear preparation of the blood agar 
plate (Gram stain, ×1,000, right).
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ported, which is higher compared to endocarditis caused by 
viridians streptococci (0-12%) [4]. The relapse rate can also be 
up to 17% in some cases. Previous studies have shown a treat-
ment failure rate as high as 41%, despite the use of appropriate 
antibiotics [5]. 
The antibiotic regimen to combat A. defectiva endocarditis 
includes penicillin or ampicillin, plus an aminoglycoside or 
vancomycin for cases of antimicrobial resistance, taken for 4-6 
weeks [16]. Infective endocarditis due to A. defectiva pro-
gresses slowly, but despite its sensitivity to antimicrobials 
~50% of cases need surgical management. Surgical treatment 
combined with concurrent antimicrobial therapy result in 
better prognoses, and the main indications for surgery are 
persistent sepsis and vegetation, severe congestive heart fail-
ure and recurrent embolism [15, 17, 18]. 
In Korea, 2 cases of infective endocarditis caused by S. adja-
cens were first reported in 1996. Since then, a case of infective 
endocarditis by Grnulicatella adjacens was reported in 2010. 
All cases were successfully treated with antibiotics and surgi-
cal treatment [19, 20]. After classified as A. defectiva, this is the 
first report as the pathogen of infective endocarditis in Korea. 
The case presented here is an example of the successful 
treatment of infective endocarditis caused by A. defectiva fol-
lowing a tooth extraction in a post-MVR patient, and rep-
resents the first reported case of infective endocarditis caused 
by A. defectiva in Korea. This case shows that A. defectiva 
could be considered as a causative organism of infective en-
docarditis in Korea.
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